Literature DB >> 33096356

Adjunct high-frequency transcranial random noise stimulation over the lateral prefrontal cortex improves negative symptoms of schizophrenia: A randomized, double-blind, sham-controlled pilot study.

Chuan-Chia Chang1, Yen-Yue Lin2, Nian-Sheng Tzeng1, Yu-Chen Kao3, Hsin-An Chang4.   

Abstract

High-frequency transcranial random noise stimulation (hf-tRNS) is a non-invasive neuromodulatory technique capable of increasing human cortex excitability. There were only published case reports on the use of hf-tRNS targeting the lateral prefrontal cortex in treating negative symptoms of schizophrenia, thus necessitating systematic investigation. We designed a randomized, double-blind, sham-controlled trial in a cohort of stabilized schizophrenia patients to examine the efficacy of add-on hf-tRNS (100-640 Hz; 2 mA; 20 min) using a high definition 4 × 1 electrode montage (anode AF3, cathodes AF4, F2, F6, and FC4) in treating negative symptoms (ClinicalTrials.gov ID: NCT04038788). Participants received either active hf-tRNS or sham twice daily for 5 consecutive weekdays. Primary outcome measure was the change over time in the Positive and Negative Syndrome Scale Factor Score for Negative Symptoms (PANSS-FSNS), which was measured at baseline, after 10-session stimulation, and at one-week and one-month follow-ups. Among 36 randomized patients, 35 (97.2%) completed the trial. Intention-to-treat analysis showed a significantly greater decrease in PANSS-FSNS score after active (-17.11%) than after sham stimulation (-1.68%), with a large effect size (Cohen's d = 2.16, p < 0.001). The beneficial effect lasted for up to one month. In secondary-outcome analyses, the authors observed improvements with hf-tRNS of disorganization symptoms, unawareness of negative symptoms, subjective response to taking antipsychotics, and antipsychotic-induced extrapyramidal symptoms. No effects were observed on the neurocognitive performance and other outcome measures. Overall, hf-tRNS was safe and efficacious in improving negative symptoms. Our promising findings should be confirmed in a larger sample of patients with predominant negative symptoms.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  High definition montage; Negative symptoms; Prefrontal cortex; Schizophrenia; Transcranial random noise stimulation

Mesh:

Year:  2020        PMID: 33096356     DOI: 10.1016/j.jpsychires.2020.10.008

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  4 in total

Review 1.  Random noise stimulation in the treatment of patients with neurological disorders.

Authors:  Mateo A Herrera-Murillo; Mario Treviño; Elias Manjarrez
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

Review 2.  New Horizons on Non-invasive Brain Stimulation of the Social and Affective Cerebellum.

Authors:  Z Cattaneo; C Ferrari; A Ciricugno; E Heleven; D J L G Schutter; M Manto; F Van Overwalle
Journal:  Cerebellum       Date:  2021-07-16       Impact factor: 3.847

3.  Examining transcranial random noise stimulation as an add-on treatment for persistent symptoms in schizophrenia (STIM'Zo): a study protocol for a multicentre, double-blind, randomized sham-controlled clinical trial.

Authors:  Jerome Brunelin; Marine Mondino; Julie Haesebaert; Jerome Attal; Michel Benoit; Marie Chupin; Sonia Dollfus; Wissam El-Hage; Filipe Galvao; Renaud Jardri; Pierre Michel Llorca; Laurent Magaud; Marion Plaze; Anne Marie Schott-Pethelaz; Marie-Françoise Suaud-Chagny; David Szekely; Eric Fakra; Emmanuel Poulet
Journal:  Trials       Date:  2021-12-28       Impact factor: 2.279

Review 4.  Update Research Advances in the Application of Transcranial Magnetic Stimulation in the Treatment of Schizophrenia.

Authors:  Yanhai Wu; Zucheng Yang; Shu Cui
Journal:  Scanning       Date:  2022-09-12       Impact factor: 1.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.